Subscribe to Newsletter

Content by Stephanie Vine:

 Manufacture Business Practice

The Worst of Side Effects

| Stephanie Vine

Is growing awareness of unwanted drug effects good or bad for patients?
Discovery & Development Small Molecules

Bringing API Manufacture into Focus

| Stephanie Vine

The industry is shifting towards biopharmaceuticals, but there is still demand for synthetic APIs.

Business & Regulation Standards & Regulation

Catching Cargo Criminals

| Stephanie Vine

How does the FBI track down culprits of pharma heists?
Business & Regulation

Medical Miners

| Stephanie Vine

Intrepid researchers scour disused mines in search of new biochemistries for drug development.
Business & Regulation Business Practice

Celebrating the Power List

| Stephanie Vine

Celebrating the great and good of drug development: welcome to The Medicine Maker 2017 Power List
Manufacture Clinical Trials

Weeding Out Pain

| Stephanie Vine

What does patient preference for pot over prescriptions mean for the pharma industry?
Discovery & Development Packaging

The Art of Science

| Stephanie Vine

An art gallery at Pharmapack showcased the artistic side of primary drug packaging
Business & Regulation Business Practice

Do Not Go Gentle Into That Good Night

| Stephanie Vine

PhRMA and the ABPI showcase the industry’s good side and the science behind the logo.
Manufacture Business Practice

Revelations and Resolutions

| Stephanie Vine

What was hot in 2016? And what should pharma's priorities lie in 2017?
Manufacture Business Practice

Failure to Engage

| Stephanie Vine

Could public health suffer if the pharma industry doesn’t learn to win back trust?
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker